Gelfoam Plus Hemostasis Kit approved to control surgical bleeding

The FDA has approved Gelfoam Plus Hemostasis Kit, a combination hemostasis product that contains Pfizer's Gelfoam Sterile Sponge and Baxter's Thrombin (Human) dried powder for use in controlling bleeding during surgery. Gelfoam Sterile Sponge is indicated as a hemostatic device for surgical procedures when control of capillary, venous and arteriolar bleeding by pressure, ligature and conventional procedures is either ineffective or impractical. Thrombin (Human) dried powder is used as a component in hemostatic agents and sealants for adjunctive therapy during surgical procedures. Baxter will assemble, promote and exclusively distribute the Gelfoam Plus Hemostasis Kit.

For more information call (800)-4Baxter or visit www.baxter.com.